Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STER
2226
DELISTED
Sterling Check Corp. Common Stock
STER
| $305K | ﹤0.01% |
21,905
-260
| -1% | -$3.27K |
|
2227
Southern Missouri Bancorp
SMBC
$852M
| $305K | ﹤0.01% |
5,715
-8
| -0.1% | -$356 |
|
2228
Smith & Wesson
SWBI
$669M
| $304K | ﹤0.01% |
22,423
-37
| -0.2% | -$509 |
|
|
PETQ
2229
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $303K | ﹤0.01% |
+15,338
| New | +$295K |
|
2230
ImmunityBio
IBRX
$7.8B
| $303K | ﹤0.01% |
60,515
-1
| -0% | -$3 |
|
2231
Douglas Dynamics
PLOW
$991M
| $302K | ﹤0.01% |
10,166
-18
| -0.2% | -$517 |
|
2232
Corsair Gaming
CRSR
$1.14B
| $302K | ﹤0.01% |
21,389
-32
| -0.1% | -$429 |
|
|
BRSP
2233
BrightSpire Capital
BRSP
$633M
| $301K | ﹤0.01% |
40,418
-47
| -0.1% | -$307 |
|
2234
Atlanticus Holdings
ATLC
$1.6B
| $301K | ﹤0.01% |
+7,768
| New | +$245K |
|
2235
Anavex Life Sciences
AVXL
$250M
| $300K | ﹤0.01% |
32,209
-64
| -0.2% | -$441 |
|
2236
HealthStream
HSTM
$824M
| $299K | ﹤0.01% |
11,069
-21
| -0.2% | -$522 |
|
2237
IDT Corp
IDT
$1.64B
| $298K | ﹤0.01% |
+8,761
| New | +$258K |
|
2238
Genie Energy
GNE
$373M
| $297K | ﹤0.01% |
+10,567
| New | +$243K |
|
2239
Amplitude
AMPL
$1.14B
| $295K | ﹤0.01% |
23,188
-14
| -0.1% | -$155 |
|
2240
Bank First Corp
BFC
$1.68B
| $294K | ﹤0.01% |
3,386
-1,896
| -36% | -$157K |
|
2241
Univest Financial
UVSP
$1.22B
| $293K | ﹤0.01% |
13,327
-24
| -0.2% | -$450 |
|
|
DENN
2242
DELISTED
Denny's
DENN
| $292K | ﹤0.01% |
26,863
-55
| -0.2% | -$517 |
|
|
CTLP
2243
DELISTED
Cantaloupe
CTLP
| $291K | ﹤0.01% |
39,308
+12,903
| +49% | +$89.1K |
|
2244
Viridian Therapeutics
VRDN
$2.2B
| $291K | ﹤0.01% |
13,364
-31
| -0.2% | -$489 |
|
|
XRN
2245
Chiron Real Estate Inc
XRN
$516M
| $290K | ﹤0.01% |
5,229
-10
| -0.2% | -$485 |
|
2246
Stem
STEM
$47.5M
| $290K | ﹤0.01% |
3,743
-5
| -0.1% | -$345 |
|
2247
ANI Pharmaceuticals
ANIP
$1.83B
| $290K | ﹤0.01% |
5,258
-11
| -0.2% | -$606 |
|
2248
QuinStreet
QNST
$890M
| $289K | ﹤0.01% |
22,584
-43
| -0.2% | -$484 |
|
|
EFC
2249
Ellington Financial
EFC
$1.69B
| $289K | ﹤0.01% |
22,739
-51
| -0.2% | -$647 |
|
2250
Travere Therapeutics
TVTX
$5.33B
| $289K | ﹤0.01% |
32,180
-55
| -0.2% | -$400 |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.